Page last updated: 2024-08-24

imiquimod and methanol

imiquimod has been researched along with methanol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alalaiwe, A; Fang, JY; Huang, TH; Lin, ZC; Weng, JR	1

Other Studies

1 other study(ies) available for imiquimod and methanol

Article	Year
Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 119 Topics: Administration, Cutaneous; Animals; Cell Line; Drug Delivery Systems; Humans; Imiquimod; Indoles; Male; Methanol; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; NF-kappa B; Nitrobenzenes; Phosphorylation; Psoriasis; Transcription Factor AP-1; Tumor Necrosis Factor-alpha	2019

Article

Year

Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 119

Topics: Administration, Cutaneous; Animals; Cell Line; Drug Delivery Systems; Humans; Imiquimod; Indoles; Male; Methanol; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; NF-kappa B; Nitrobenzenes; Phosphorylation; Psoriasis; Transcription Factor AP-1; Tumor Necrosis Factor-alpha

2019